Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2026-03-03 @ 3:06 PM
Study NCT ID:
NCT02523105
Status:
COMPLETED
Last Update Posted:
2018-04-26
First Post:
2015-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment
Sponsor:
Brainmarc Ltd.
Organization:
Study Overview
Official Title:
Evaluation of Use of Brain Activity Monitoring for Early Identification of Pharmaceutical Treatment Efficacy and Development of Depression Deterioration Events.
Status:
COMPLETED
Status Verified Date:
2016-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the use of brain activity monitoring for early identification of pharmaceutical treatment efficacy and development of depression deterioration events.
Detailed Description:
The study will be conducted in two arms:
In arm I, participants diagnosed with depression. In arm II, healthy participants.
Arm I - Participants that need to start or switch their pharmacological antidepressant therapy will be recruited. Their clinical status will be evaluated and their EEG characteristics will be collected.
Arm II - Clinical and EEG characteristics of Healthy volunteers will collected on a similar timetable.
In arm I, participants diagnosed with depression. In arm II, healthy participants.
Arm I - Participants that need to start or switch their pharmacological antidepressant therapy will be recruited. Their clinical status will be evaluated and their EEG characteristics will be collected.
Arm II - Clinical and EEG characteristics of Healthy volunteers will collected on a similar timetable.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: